3740 F420-reducing hydrogenase subunit beta
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic nitrogen compounds | 1 | 0.2 | 5.30× | not tested | |
| Nucleosides, nucleotides, and analogues | 6 | 1.6 | 3.67× | not tested | |
| Homogeneous non-metal compounds | 2 | 1.3 | 1.57× | not tested | |
| Organic acids and derivatives | 1 | 0.9 | 1.09× | not tested | |
| Homogeneous metal compounds | 2 | 2.9 | 0.69× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 32 |
| DB02832 | SRM | Siroheme | 3 |
| DB03913 | F42 | Coenzyme F420 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SF4 | IRON/SULFUR CLUSTER | 56 |
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 55 |
| CL | CHLORIDE ION | 20 |
| CAmetal | CALCIUM ION | 4 |
| NAmetal | SODIUM ION | 3 |
| F42 | COENZYME F420 | 1 |
| FEmetal | FE (III) ION | 1 |
| KEN | N,N-dimethylmethanamine | 1 |